Consumer Goods » Food, Beverages & Tobacco | BioGaia AB

BioGaia AB Series B | Mutual Funds

Mutual Funds that own BioGaia AB Series B

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Swedbank Robur Ny Teknik
1,261,922
7.6%
0
2.64%
07/31/2018
Fjarde AP Fonden
1,017,533
6.13%
1,017,533
0.13%
12/31/2016
Government Pension Fund - Global (The)
458,958
2.77%
3,023
0%
12/31/2017
AMF Aktiefond Smabolag
236,899
1.43%
0
1.41%
12/31/2017
Allianz Global Investors Fund - Europe Small Cap Equity
205,192
1.24%
0
1.35%
05/31/2018
Swedbank Robur Småbolag Sverige
200,000
1.21%
0
0.56%
07/31/2018
Nordea Smabolagsfond Sverige
171,564
1.03%
-2,408
1.09%
05/31/2018
DNB Sweden Micro Cap
150,505
0.91%
25,971
2.29%
12/31/2017
Tredje AP Fonden
144,738
0.87%
0
0.02%
06/30/2017
133,457
0.8%
0
2.17%
07/31/2018

About BioGaia AB

View Profile
Address
Kungsbroplan 3
Stockholm AB 112 27
Sweden
Employees -
Website http://www.biogaia.com
Updated 07/08/2019
BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment is comprised of sales of drops, oral rehydration solutions (ORS), digestive health tablets and also cultures as an ingredient in a licensee's products, as well as royalties pertaining to pediatric products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.